Compare VTRS & SMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTRS | SMCI |
|---|---|---|
| Founded | 1961 | 1993 |
| Country | United States | United States |
| Employees | 30000 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.3B | 19.8B |
| IPO Year | 2019 | 2006 |
| Metric | VTRS | SMCI |
|---|---|---|
| Price | $15.98 | $32.92 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 18 |
| Target Price | $13.50 | ★ $34.69 |
| AVG Volume (30 Days) | 9.0M | ★ 66.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.21% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.15 | ★ 1.59 |
| Revenue | ★ $14,299,900,000.00 | $2,484,929,000.00 |
| Revenue This Year | $4.41 | $92.37 |
| Revenue Next Year | $1.96 | $21.47 |
| P/E Ratio | $105.00 | ★ $20.92 |
| Revenue Growth | N/A | ★ 11.68 |
| 52 Week Low | $8.63 | $19.48 |
| 52 Week High | $17.53 | $62.36 |
| Indicator | VTRS | SMCI |
|---|---|---|
| Relative Strength Index (RSI) | 51.24 | 47.26 |
| Support Level | $15.50 | $28.83 |
| Resistance Level | $16.54 | $33.66 |
| Average True Range (ATR) | 0.47 | 3.20 |
| MACD | -0.07 | -0.83 |
| Stochastic Oscillator | 60.97 | 25.78 |
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
Super Micro Computer Inc provides high-performance server technology services to cloud computing, data centers, high-performance computing, and the Internet of Things embedded markets. Its solutions include servers, storage systems, modular blade servers, workstations, full-rack scale solutions, networking devices, server sub-systems, and server management. These turn-key solutions are designed, developed, validated, and installed for AI datacenters. The company has one operating segment that develops and provides high-performance server solutions based upon a, modular and open-standard architecture. More than half of the firm's revenue is generated in the United States, with the rest coming from Europe, Asia, and other regions.